New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
06:55 EDTTPI, TPI, TPI, ANX, ANX, ANX, AGEN, AGEN, AGEN, CTSO, CTSO, CTSO, ATOS, ATOS, ATOS, SYN, SYN, SYN, OXBT, OXBT, OXBT, CLRX, CLRX, CLRX, BONE, BONE, BONEOneMedPlace to host a forum
6th Annual OneMedForum 2013 is being held in San Francisco on January 7-9.
News For TPI;ANX;AGEN;CTSO;ATOS;SYN;OXBT;CLRX;BONE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2015
06:00 EDTCTSOCytoSorbents management to meet with Benchmark Co
Subscribe for More Information
July 27, 2015
19:03 EDTBONEBacterin to acquire X-spine Systems, change name of new company to Xtant Medical
Bacterin announced that it intends to purchase the outstanding shares of privately held X-spine Systems in exchange for approximately 4.24M shares of Bacterin common stock and approximately $60M in cash, subject to customary working capital adjustments, and including the extinguishment of approximately $13M of X-spine debt. The transaction will position the combined company as a comprehensive supplier for spine surgery procedures that offers both hardware and biologics through a more substantial national distribution footprint. Concurrent with the closing, Bacterin International Holdings, Inc. will change its name to Xtant Medical Holdings, Inc. Dr. David Kirschman, currently X-spine CEO, will join the management team and serve as EVP and Chief Scientific Officer of Xtant Medical Holdings, Inc. He will also be president of X-spine Systems, the hardware subsidiary. Dr. Kirschman will also be appointed to the Xtant Medical Holdings, Inc. board.
July 24, 2015
05:04 EDTAGENAgenus reports GSK Malaria vaccine receives positive opinion from CHMP of EMA
Subscribe for More Information
July 23, 2015
08:23 EDTCTSOCytoSorbents signs CytoSorb distribution agreement for Australia and New Zealand
Subscribe for More Information
08:14 EDTCTSOCytoSorbents files $100M mixed securities shelf, 2.5M shares for holder
Subscribe for More Information
07:14 EDTAGENAgenus reports Q2 EPS (53c), consensus (15c)
Subscribe for More Information
July 20, 2015
07:02 EDTAGENAgenus acquires novel antibodies to immuno-oncology target CEACAM1
Subscribe for More Information
July 16, 2015
08:19 EDTSYNSynthetic Biologics 13.33M share Spot Secondary priced at $3.00
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use